Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex.

scientific article

Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7554/ELIFE.10222
P932PMC publication ID4786417
P698PubMed publication ID26651998

P50authorJordan D CarelliQ86881209
Geoffrey A SmithQ86881211
P2093author name stringWilliam C Merrick
Jack Taunton
Nathan T Ross
Rishi K Jain
Steven G Sethofer
Howard R Miller
Jillian L Simard
P2860cites workConformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodoxQ27630920
Structural basis for mRNA surveillance by archaeal Pelota and GTP-bound EF1α complexQ27664700
Kinetics of the interactions between yeast elongation factors 1A and 1Balpha, guanine nucleotides, and aminoacyl-tRNA.Q27937618
Enzymatic assembly of DNA molecules up to several hundred kilobasesQ28241142
Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1Q28261510
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3pQ28276243
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesQ28277749
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityQ29547693
Aminoacyl-tRNA-charged eukaryotic elongation factor 1A is the bona fide substrate for Legionella pneumophila effector glucosyltransferasesQ34117671
Elongation factors in protein biosynthesisQ34224585
Inhibition of translation by cytotrienin A--a member of the ansamycin familyQ34370125
FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.Q34472558
Natural products as probes of cell biology: 20 years of didemnin researchQ34540054
Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocationQ34709968
Decatransin, a new natural product inhibiting protein translocation at the Sec61/SecYEG transloconQ35178294
How proteins bind macrocycles.Q35209183
Cell-permeable cyclic peptides from synthetic libraries inspired by natural products.Q35526966
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin BQ35612950
Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative PropertiesQ35648635
Preparation and evaluation of acylated tRNAs.Q36513229
The exploration of macrocycles for drug discovery--an underexploited structural classQ37203934
Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosisQ37635859
Form and function in cyclic peptide natural products: a pharmacokinetic perspectiveQ38098254
Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?Q38138640
Mechanism of action of kirromycin-like antibioticsQ39833930
Target Identification by Diazirine Photo-Cross-linking and Click ChemistryQ40513067
Assays for eukaryotic protein synthesisQ41697895
Mitotic modulation of translation elongation factor 1 leads to hindered tRNA delivery to ribosomes.Q42148482
Design, synthesis, and biological evaluation of biotin-labeled (-)-ternatin, a potent fat-accumulation inhibitor against 3T3-L1 adipocytesQ42806016
Whole structure-activity relationships of the fat-accumulation inhibitor (-)-ternatin: recognition of the importance of each amino acid residueQ42808422
Synthesis and inhibitory effect on fat accumulation of (-)-ternatin derivatives modified in the beta-OH-D-Leu(7) moietyQ42819396
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vectorQ45874327
A substrate-specific inhibitor of protein translocation into the endoplasmic reticulumQ46562004
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer PropertiesQ46699912
The antiproliferative agent didemnin B uncompetitively inhibits palmitoyl protein thioesteraseQ47813181
Purification of various forms of elongation factor 1 from rabbit reticulocytesQ70666156
Mechanism of protein synthesis inhibition by didemnin B in vitroQ71910192
GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alphaQ72465820
Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cellsQ73423107
Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocationQ73660191
Convergent synthesis and in vivo inhibitory effect on fat accumulation of (-)-ternatin, a highly N-methylated cyclic peptideQ80523611
P407language of work or nameEnglishQ1860
P577publication date2015-12-10
P1433published ineLifeQ2000008
P1476titleTernatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex
P478volume4

Reverse relations

cites work (P2860)
Q94470555A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Q91031402A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
Q37430049Decoding Mammalian Ribosome-mRNA States by Translational GTPase Complexes
Q99634692Evaluation on Elongation Factor 1 Alpha of Entamoeba histolytica Interaction with the Intermediate Subunit of the Gal/GalNAc Lectin and Actin in Phagocytosis
Q41456951In vitro analysis of RQC activities provides insights into the mechanism and function of CAT tailing.
Q46107918Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States
Q90614482Recent Trends in Cyclic Peptides as Therapeutic Agents and Biochemical Tools
Q90669066Seeking Convergence and Cure with New Myeloma Therapies
Q47813312Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B.
Q53076019Translation Elongation and Recoding in Eukaryotes.